190 related articles for article (PubMed ID: 23819021)
21. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
[TBL] [Abstract][Full Text] [Related]
22. Polyethylenimine-Coated Ultrasmall Holmium Oxide Nanoparticles: Synthesis, Characterization, Cytotoxicities, and Water Proton Spin Relaxivities.
Liu S; Yue H; Ho SL; Kim S; Park JA; Tegafaw T; Ahmad MY; Kim S; Saidi AKAA; Zhao D; Liu Y; Nam SW; Chae KS; Chang Y; Lee GH
Nanomaterials (Basel); 2022 May; 12(9):. PubMed ID: 35564300
[TBL] [Abstract][Full Text] [Related]
23. Polyethyleneimine-mediated synthesis of superparamagnetic iron oxide nanoparticles with enhanced sensitivity in T2 magnetic resonance imaging.
Do MA; Yoon GJ; Yeum JH; Han M; Chang Y; Choi JH
Colloids Surf B Biointerfaces; 2014 Oct; 122():752-759. PubMed ID: 25194592
[TBL] [Abstract][Full Text] [Related]
24. Local spin dynamics of iron oxide magnetic nanoparticles dispersed in different solvents with variable size and shape: A
Basini M; Orlando T; Arosio P; Casula MF; Espa D; Murgia S; Sangregorio C; Innocenti C; Lascialfari A
J Chem Phys; 2017 Jan; 146(3):034703. PubMed ID: 28109242
[TBL] [Abstract][Full Text] [Related]
25. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
26. Biodegradable and biocompatible exceedingly small magnetic iron oxide nanoparticles for T
Lu X; Zhou H; Liang Z; Feng J; Lu Y; Huang L; Qiu X; Xu Y; Shen Z
J Nanobiotechnology; 2022 Jul; 20(1):350. PubMed ID: 35908057
[TBL] [Abstract][Full Text] [Related]
27. The effects of particle shape and size on T2 relaxation in magnetic resonance imaging.
York JN; Albanese C; Rodriguez O; Le YC; Ackun-Farmmer M; Van Keuren E
J Biomed Nanotechnol; 2014 Nov; 10(11):3392-6. PubMed ID: 26000397
[TBL] [Abstract][Full Text] [Related]
28. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic T1-weighted MR imaging.
Reimer P; Müller M; Marx C; Wiedermann D; Muller R; Rummeny EJ; Ebert W; Shamsi K; Peters PE
Radiology; 1998 Dec; 209(3):831-6. PubMed ID: 9844683
[TBL] [Abstract][Full Text] [Related]
29. Architectured design of superparamagnetic Fe
Pereira C; Pereira AM; Rocha M; Freire C; Geraldes CFGC
J Mater Chem B; 2015 Aug; 3(30):6261-6273. PubMed ID: 32262745
[TBL] [Abstract][Full Text] [Related]
30. Synergetic effect of size and morphology of cobalt ferrite nanoparticles on proton relaxivity.
N V; Srivastava C; Hegde V
IET Nanobiotechnol; 2014 Dec; 8(4):184-9. PubMed ID: 25429495
[TBL] [Abstract][Full Text] [Related]
31. Ligand-size dependent water proton relaxivities in ultrasmall gadolinium oxide nanoparticles and in vivo T1 MR images in a 1.5 T MR field.
Kim CR; Baeck JS; Chang Y; Bae JE; Chae KS; Lee GH
Phys Chem Chem Phys; 2014 Oct; 16(37):19866-73. PubMed ID: 25123195
[TBL] [Abstract][Full Text] [Related]
32. A new class of cubic SPIONs as a dual-mode T1 and T2 contrast agent for MRI.
Alipour A; Soran-Erdem Z; Utkur M; Sharma VK; Algin O; Saritas EU; Demir HV
Magn Reson Imaging; 2018 Jun; 49():16-24. PubMed ID: 28958878
[TBL] [Abstract][Full Text] [Related]
33. Fluoride doped γ-Fe
Jones NE; Burnett CA; Salamon S; Landers J; Wende H; Lazzarini L; Gibbs P; Pickles M; Johnson BRG; Evans DJ; Archibald SJ; Francesconi MG
J Mater Chem B; 2018 Jun; 6(22):3665-3673. PubMed ID: 32254829
[TBL] [Abstract][Full Text] [Related]
34. Surface Design of Eu-Doped Iron Oxide Nanoparticles for Tuning the Magnetic Relaxivity.
Park JC; Lee GT; Kim HK; Sung B; Lee Y; Kim M; Chang Y; Seo JH
ACS Appl Mater Interfaces; 2018 Aug; 10(30):25080-25089. PubMed ID: 29989402
[TBL] [Abstract][Full Text] [Related]
35. Cobalt nanoparticles as a novel magnetic resonance contrast agent--relaxivities at 1.5 and 3 Tesla.
Parkes LM; Hodgson R; Lu le T; Tung le D; Robinson I; Fernig DG; Thanh NT
Contrast Media Mol Imaging; 2008; 3(4):150-6. PubMed ID: 18756588
[TBL] [Abstract][Full Text] [Related]
36. Toward design of magnetic nanoparticle clusters stabilized by biocompatible diblock copolymers for T₂-weighted MRI contrast.
Balasubramaniam S; Kayandan S; Lin YN; Kelly DF; House MJ; Woodward RC; St Pierre TG; Riffle JS; Davis RM
Langmuir; 2014 Feb; 30(6):1580-7. PubMed ID: 24479874
[TBL] [Abstract][Full Text] [Related]
37. Exceedingly Small Magnetic Iron Oxide Nanoparticles for T
Yang J; Feng J; Yang S; Xu Y; Shen Z
Small; 2023 Dec; 19(49):e2302856. PubMed ID: 37596716
[TBL] [Abstract][Full Text] [Related]
38. Determining the relaxivity values of protein cage-templated nanoparticles using magnetic resonance imaging.
Sana B; Lim S
Methods Mol Biol; 2015; 1252():39-50. PubMed ID: 25358771
[TBL] [Abstract][Full Text] [Related]
39. Fabricating High-Performance T
Xiao J; Zhang G; Qian J; Sun X; Tian J; Zhong K; Cai D; Wu Z
ACS Appl Mater Interfaces; 2018 Feb; 10(8):7003-7011. PubMed ID: 29392939
[TBL] [Abstract][Full Text] [Related]
40. Ultracompact Iron Oxide Nanoparticles with a Monolayer Coating of Succinylated Heparin: A New Class of Renal-Clearable and Nontoxic T
Xie M; Wang Z; Lu Q; Nie S; Butch CJ; Wang Y; Dai B
ACS Appl Mater Interfaces; 2020 Dec; 12(48):53994-54004. PubMed ID: 33210906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
